Human Genome Epidemiology Literature Finder
|
Records 1 - 5 (of 5 Records) |
| Query Trace: Pancreatic Neoplasms and TYMS[original query] |
|---|
| Genetic polymorphisms associated with 5-Fluorouracil-induced neurotoxicity. Chemotherapy 2010 56 (4): 313-7. Kim Suk-Ran, Park Chang-Hun, Park Silvia, Park Joon-Oh, Lee Jeeyun, Lee Soo-Yo |
| Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer. Investigational new drugs 2011 Oct 29 (5): 1057-65. Weekes Colin D, Nallapareddy Sujatha, Rudek Michelle A, Norris-Kirby Alexis, Laheru Daniel, Jimeno Antonio, Donehower Ross C, Murphy Kathleen M, Hidalgo Manuel, Baker Sharyn D, Messersmith Wells |
| Genetic effects and modifiers of radiotherapy and chemotherapy on survival in pancreatic cancer. Pancreas 2011 Jul 40 (5): 657-63. Zeng Hongmei, Yu Herbert, Lu Lingeng, Jain Dhanpat, Kidd Mark S, Saif M Wasif, Chanock Stephen J, Hartge Patricia, , Risch Harvey |
| A metabolism-relevant signature as a predictor for prognosis and therapeutic response in pancreatic cancer. Experimental biology and medicine (Maywood, N.J.) 2021 10 247 (2): 120-130. Chen Qiangda, Pu Ning, Yin Hanlin, Zhang Jicheng, Zhao Guochao, Lou Wenhui, Wu Wenchu |
| TYMS 3'-UTR Polymorphism: A Novel Association with FOLFIRINOX-Induced Neurotoxicity in Pancreatic Cancer Patients. Pharmaceutics 2021 Dec 14 (1): . Emelyanova Marina, Pokataev Ilya, Shashkov Igor, Kopantseva Elena, Lyadov Vladimir, Heydarov Rustam, Mikhailovich Vladim |
- Page last reviewed:Feb 1, 2024
- Content source: